Cargando…
Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy
PURPOSE: The subcutaneous implantable defibrillator (S-ICD) was developed to avoid complications related to transvenous leads. A trade-off with the S-ICD is the inability to deliver antitachycardia pacing (ATP). Data is scarce about the recurrence and characteristics of ventricular tachyarrhythmias...
Autores principales: | Theuns, Dominic A. M. J., Bhagwandien, Rohit E., Szili-Torok, Tamas, Zijlstra, Felix, Yap, Sing-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694073/ https://www.ncbi.nlm.nih.gov/pubmed/30478809 http://dx.doi.org/10.1007/s10840-018-0490-4 |
Ejemplares similares
-
Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
por: Yap, Sing-Chien, et al.
Publicado: (2015) -
Substernal ICD lead implantation in a patient not suitable for subcutaneous ICD implantation without venous access due to superior vena cava syndrome
por: Bhagwandien, Rohit E., et al.
Publicado: (2016) -
Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists
por: de Heide, John, et al.
Publicado: (2022) -
Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
por: Assaf, Amira, et al.
Publicado: (2022) -
Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)